Dong L. Dai

Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Design, Synthesis, and Evaluation of [68Ga/177Lu]-Labeled TSPO-Targeting Radioligands for PET/CT Diagnosis and Radionuclide Therapy of Brain Tumor.

Design, Synthesis, and Evaluation of [68Ga/177Lu]-Labeled TSPO-Targeting Radioligands for PET/CT Diagnosis and Radionuclide Therapy of Brain Tumor.

Journal: Journal of medicinal chemistry

Published: June 17, 2026

Synthesis, Evaluation, and First-in-Human Study of a Novel PSMA Radioligand Bearing Beta3-Amino Acid Linkage.

Synthesis, Evaluation, and First-in-Human Study of a Novel PSMA Radioligand Bearing Beta3-Amino Acid Linkage.

Journal: Journal of medicinal chemistry

Published: March 02, 2026

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy.

Fluorination augments tumor engagement and antitumor immunity of a D-peptide-based radiotheranostic agent for combinatorial immune checkpoint blockade therapy.

Journal: Journal for immunotherapy of cancer

Published: February 18, 2026

Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers.

Editorial: Development and validation of new molecular probes of nuclear medicine and new targets of nuclear drugs in cancers.

Journal: Frontiers in oncology

Published: February 17, 2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Journal: Lancet (London, England)

Published: February 09, 2026

First-in-human evaluation of four novel PSMA-targeted PET radiotracers with non-canonical amino acid linkage: A comparative study.

First-in-human evaluation of four novel PSMA-targeted PET radiotracers with non-canonical amino acid linkage: A comparative study.

Journal: Pharmacological research

Published: January 22, 2026

Non-invasive prediction of prognostic immune subtypes in lung adenocarcinoma using PET/CT-based radiomics.

Non-invasive prediction of prognostic immune subtypes in lung adenocarcinoma using PET/CT-based radiomics.

Journal: Frontiers in oncology

Published: November 04, 2025

Linker Manipulation with Beta3-Amino Acids Potentiates the Efficacy and Safety of PSMA Radiopharmaceuticals.

Linker Manipulation with Beta3-Amino Acids Potentiates the Efficacy and Safety of PSMA Radiopharmaceuticals.

Journal: Advanced healthcare materials

Published: October 15, 2025

Optimized CDK19 PET Tracers: Spirocyclic-Driven Design and Prostate Cancer Imaging.

Optimized CDK19 PET Tracers: Spirocyclic-Driven Design and Prostate Cancer Imaging.

Journal: Journal of medicinal chemistry

Published: July 18, 2025

The value of 18F-FDG PET/CT imaging in predicting the efficacy of PD-1/PD-L1 immune checkpoint inhibitors in advanced non-small cell lung cancer.

The value of 18F-FDG PET/CT imaging in predicting the efficacy of PD-1/PD-L1 immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Frontiers in oncology

Published: June 22, 2025

Efficacy and safety of anlotinib in combination with ¹³¹I therapy in the treatment of distant metastatic differentiated thyroid cancer: a single-arm, phase II study.

Efficacy and safety of anlotinib in combination with ¹³¹I therapy in the treatment of distant metastatic differentiated thyroid cancer: a single-arm, phase II study.

Journal: Frontiers in oncology

Published: May 04, 2025

Synthesis and Imaging of Novel CDK19-Targeted Tracers Incorporating an Albumin-Binding Moiety.

Synthesis and Imaging of Novel CDK19-Targeted Tracers Incorporating an Albumin-Binding Moiety.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: March 13, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026